Inhibitors of Enhancer of Zeste Homologue 2 (EZH2) as Treatment for Cancer, Autoimmune, and Other Diseases.

The invention in this patent application relates to 2-amino-7-aza-quinoline derivatives represented herein by formula 1. These compounds are inhibitors of the enhancer of zeste homologue 2 (EZH2), and may potentially provide useful treatment for a disease or condition mediated by EZH2 and PRC2-EZH2 complex such as breast cancer, prostate cancer, hepatocellular carcinoma and possibly other cancers.